On Tuesday, French AI startup Mistral AI released Devstral 2, a 123 billion parameter open-weights coding model designed to ...

Shares of Humana Inc. took a hit in early Wednesday trading, as the health insurer cut its outlook for both Medicaid-membership growth and the profitability of its overall insurance business. While ...

Alphabet’s stock has rallied over the past several months, and calling it technically overbought is an understatement. But is that actually a bad thing for those who already own the stock? There’s ...

The stock market enjoyed a strong opening to the week with the tech-heavy Nasdaq up nearly 600 points. NBC’s Christine Romans joins TODAY to break down how part of the Wall Street enthusiasm stems ...

Thursday, November 20, ended up being a bit of a whirlwind for tech investors. The day started off on a positive note, with Nvidia’s shares (Nasdaq: NVDA) rising almost 5% thanks to a strong earnings ...

Rocket Pharmaceuticals (RCKT) traded lower on Tuesday after J.P. Morgan downgraded the gene therapy developer to Underweight from Neutral, citing concerns over its mid-stage trial program for RP-A501, ...

📉 This is an abridged online version of my Markets A.M. newsletter. Get investing insights in your inbox each weekday by signing up here—it’s free. 📧 Some shoppers glance at the label, while others ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...

Corcept Therapeutics CORT reported third-quarter 2025 earnings of 16 cents per share, which missed the Zacks Consensus Estimate of 18 cents. The company had reported earnings of 41 cents per share in ...